Platelet-Expressed TNFRSF13B (TACI) Predicts Breast Cancer Progression
Although treatment options in breast cancer have been improved significantly, predictive biomarkers for disease progression and metastasis are still lacking. Recent studies indicate that several TNF Receptor Superfamily members are involved in breast cancer cell proliferation and survival. Interesti...
Main Authors: | Clemens Hinterleitner, Yanjun Zhou, Claudia Tandler, Jonas S. Heitmann, Korbinian N. Kropp, Martina Hinterleitner, André Koch, Andreas D. Hartkopf, Lars Zender, Helmut R. Salih, Stefanie Maurer |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.642170/full |
Similar Items
-
Controversial Role of the Immune Checkpoint OX40L Expression on Platelets in Breast Cancer Progression
by: Susanne M. Rittig, et al.
Published: (2022-07-01) -
Regulation of Platelet-Derived ADAM17: A Biomarker Approach for Breast Cancer?
by: Yanjun Zhou, et al.
Published: (2021-06-01) -
Diagnostic Approaches for Neuroendocrine Neoplasms of Unknown Primary (NEN-UPs) and Their Prognostic Relevance—A Retrospective, Long-Term Single-Center Experience
by: Moritz Schmidt, et al.
Published: (2023-08-01) -
Long‐term remission of small cell lung cancer after reactivation of tuberculosis following immune‐checkpoint blockade: A case report
by: Mattia Sirgiovanni, et al.
Published: (2021-03-01) -
Inflammatory Surrogate Parameters for Predicting Ifosfamide-Induced Neurotoxicity in Sarcoma Patients
by: Moritz Schmidt, et al.
Published: (2022-09-01)